The invention relates to phenylpropionamide compounds of Formula (I): and pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein A, B, R
1
, R
2
, R
3
, R
4
and R
5
are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula (I) to treat, prevent or ameliorate a disorder responsive to the activation of opioid receptors, particularly μ-opioid receptors. Compounds of the present invention are especially useful for treating pain.
The invention relates to phenylpropionamide compounds of Formula I:
and pharmaceutically acceptable salts, prodrugs, and solvates thereof, wherein A, B, R1, R2, R3, R4 and R5 are defined as set forth in the specification. The invention is also directed to the use of compounds of Formula I to treat, prevent or ameliorate a disorder responsive to the activation of opioid receptors, particularly µ-opioid receptors. Compounds of the present invention are especially useful for treating pain.
本发明涉及式 I 的苯基丙酰胺化合物:
及其药学上可接受的盐、原药和溶液,其中A、B、R1、R2、R3、R4和R5的定义如说明书所述。本发明还涉及使用式 I 的化合物治疗、预防或改善对阿片受体,特别是μ-阿片受体激活有反应的紊乱。本发明的化合物尤其适用于治疗疼痛。